Features and Benefits
Echinacea is a supporting therapy for mild upper respiratory complaints. It may assist by reducing the severity and lead to earlier resolution of symptoms of mild upper respiratory infections, colds and flu. This product contains alkylamides, a class of Echinacea compounds that contribute to phagocyte-enhancing activity.
Echinacea angustifolia (Echinacea) extract equivalent to dry root 600 mg (containing alkylamides 2.9 mg)
Echinacea purpurea (Echinacea) extract equivalent to dry root 675 mg (containing alkylamides 1.7 mg)
Dose and Usage
Adults: 1 tablet 2-3 times daily.
Children 6-12 years: 1 tablet 1-2 times daily.
Dosage may be increased for acute conditions.
The risk of allergic reaction to Echinacea is very small, especially if preparations of the root are used since these are free of pollens. Echinacea is contraindicated in patients taking immunosuppressant medication (eg transplant patients). Short-term therapy only is suggested in this instance. Caution is advised in patients receiving midazolam by injection. Discontinue 7 days prior to general anaesthesia. Not to be used in children under two years of age without medical advice.